Ensysce Biosciences CEO Dr. Lynn Kirkpatrick and Creighton University's Dr. Neel Pathak Discuss the Opioid Crisis and Next Generation Opioids
Portfolio Pulse from
Ensysce Biosciences CEO Dr. Lynn Kirkpatrick and Dr. Neel Pathak from Creighton University discussed the opioid crisis and the development of next-generation opioids on Today's Marketplace. They highlighted the use of 'clever chemistry' to create safer opioids with reduced risks of overdose and abuse.
March 03, 2025 | 3:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Ensysce Biosciences is working on next-generation opioids that are safer and less prone to abuse, as discussed by CEO Dr. Lynn Kirkpatrick on Today's Marketplace.
The discussion on Today's Marketplace highlights Ensysce's efforts in developing safer opioids, which could positively impact the company's stock by showcasing its innovative approach to a critical issue.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100